1. India Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Indo Amines Limited

Indo Amines Limited

INDOAMIN.BO
Indo Amines LimitedIN flagBombay Stock Exchange
125.50
INR
-2.90
- -
9.15BMarket Cap
Indo Amines Limited
INDOAMIN.BO
(Bombay Stock Exchange)

Recent

price

125.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
44.39
45.27
75.31
37.75
36.26
38.33
42.17
52.31
73.31
63.11
76.29
110.2
133.09
130.66
148.6
- -
157.77
Revenue per Share
0.8
0.95
2.51
0.99
0.81
1.38
2.45
2.4
3.56
1.71
5.35
3.26
5.78
5.92
7.7
- -
10.79
Basic EPS, GAAP
-0.68
-3.19
2.29
-0.52
0.99
1.32
-0.38
-2.05
-2.51
0.25
0.82
-3.43
-1.55
5.42
-6.58
- -
- -
Free Cash Flow per Basic Share
0.2
0.05
0.58
0.23
0.24
0.5
0.25
0.49
0.55
0.45
0.76
0.3
0.5
0.49
0.49
- -
- -
Dividend per Share
2.5
2.88
10.37
6.48
6.57
7.51
9.54
11.01
13.15
13.68
19.17
21.87
5
32.14
5
- -
4.94
Book Value per Share
5.47
6.36
13.21
6.42
6.42
7.38
8.94
10.39
14.25
14.66
20.37
24.43
30.44
34.52
41.83
- -
51.86
Tangible Book Value per Share
35
42
27
58
65
66
66
67
71
75
70
71
71
72
73
- -
74
Basic Weighted Avg Shares
1,565
1,913
2,001
2,206
2,340
2,526
2,790
3,489
5,204
4,716
5,345
7,791
9,412
9,435
10,787
11,597
11,597
Sales/Revenue/Turnover
4.22
6.02
6.08
5.71
5.23
7.17
8.66
8.43
7.88
4.95
9.55
5.47
7.85
7.15
7.79
8.73
8.73
Operating Margin (%)
24
34
27
59
102
121
121
123
146
195
112
141
173
153
170
215
215
Depreciation Expense
28
40
67
58
53
91
162
160
252
128
375
230
409
427
559
793
793
Net Income, GAAP
35.08
42.11
31.54
36.27
34.79
38.13
28.95
36.06
33.61
30.13
23.49
33.22
28.02
26.24
27.36
25.24
25.24
Effective Tax Rate (%)
1.8
2.1
3.34
2.61
2.24
3.6
5.81
4.58
4.85
2.72
7.01
2.96
4.34
4.53
5.18
6.84
6.84
Profit Margin (%)
53
-49
59
-13
-19
-180
-247
160
166
225
282
259
635
926
982
1,213
1,213
Working Capital
116
81
88
54
82
142
138
190
262
356
531
506
581
597
786
848
848
LT Debt
195
271
353
410
448
519
692
809
1,249
1,343
1,625
1,877
2,258
2,649
3,176
3,938
3,938
Total Equity
10.36
11.69
11.26
9.55
8.81
10.28
11.86
9.98
11.59
6.12
12.94
7.86
12.36
10.51
11.23
11.54
11.52
Return on Invested Capital (%)
8.92
9.1
10.65
9.72
9.93
12.66
17.2
13.71
15.96
8.36
16.17
9.45
16.38
16.11
18.54
28.98
21.15
Return on Capital (%)
32.77
38.39
33.62
17.6
13.09
19.79
28.78
23.42
30.27
13.11
31.69
15.95
43.03
31.97
41.65
218.57
49.47
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
2,253
- -
2,261
LT Borrowings
817
- -
848
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
73
- -
73
Market Capitalization
10,091
9,331
6,163

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
4,957
- -
5,285
Cash, Cash Equivalents & STI
74
- -
222
Accounts Receivable, Net
2,622
- -
2,815
Inventories
1,677
- -
1,783
Total Current Liabilities
3,913
- -
4,071
Payables & Accruals
- -
- -
- -
ST Debt
2,253
- -
2,261
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
23.01%
19.39%
23.97%
Free Cash Flow
-91.21%
-270.91%
-100.76%
Net Income, GAAP
39.41%
23.22%
41.92%
Sales/Revenue/Turnover
17.73%
17.73%
7.51%
Total Cash Common Dividend
- -
- -
2.67%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,436
2,529
1,940
2,494
9,435
2025
2,649
2,692
2,588
2,854
10,787
2026
2,876
2,770
2,774
3,176
11,597

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.66
1.75
1.28
- -
5.92
2025
2.63
1.91
1.52
1.68
7.7
2026
3.94
2.5
1.62
2.73
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.49
2025
- -
- -
- -
- -
0.49
2026
- -
- -
- -
- -
- -
Similar Companies
Guizhou Chanhen Chemical Corporation (002895.SZ)
Puyang Huicheng Electronic Material Co., Ltd. (300481.SZ)
Petkim Petrokimya Holding Anonim Sirketi (PETKM.IS)
DCM Shriram Industries Limited (DCMSRMIND.BO)
Solvay S.A. (SVYSF)
Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
Business
Indo Amines Limited (INDOAMIN.BO) manufactures, develops and supplies fine chemicals, specialty chemicals, performance chemicals, perfumery chemicals and active pharmaceutical ingredients worldwide. The company produces an extensive range of products including aliphatic amines such as cyclohexylamine, n-propylamine, di-n-propylamine and dimethylaminopropylamine; aromatic amines including benzylamine, dibenzylamine and p-toluidine; nitriles like propionitrile, butyronitrile and 3-methoxypropionitrile; alkyl halides such as n-butyl chloride and cyclohexyl chloride; fatty acids including oleic acid, coconut fatty acid and soya fatty acid; amines and derivatives like lauryl amine, di-lauryl amine and tallow triamine; quaternary ammonium compounds including dodecyl trimethyl ammonium chloride and benzalkonium chloride; as well as morpholines, ethanolamines, cyclohexanols and other intermediates for pharmaceuticals, agrochemicals, fertilizers, petrochemicals, pesticides, dyes, detergents, personal care and road construction applications. Incorporated in 1994 and headquartered in Dombivli, Maharashtra, India, the company operates six manufacturing facilities in India at Dombivli, Dhule, Rabale, Baroda, Tarapur and Mahad, with four additional sites under development to support capacity expansion, and serves domestic and international markets through a diversified customer base. In recent developments, Indo Amines completed the National Company Law Tribunal-approved amalgamation of Pious Engineering Private Limited in 2024, integrating operations to strengthen its business structure. The company launched Morpholine and its derivatives in fiscal year 2025 at its Dhule facility, targeting enhanced domestic and export sales in the aliphatic amines category and contributing to a 5.7% share price increase upon announcement. Financial performance reflects growth with standalone net sales reaching Rs 278.46 crore in March 2025, up 12.85% year-over-year, and Q2 FY2026 total income at Rs 281.95 crore, up 2.7% year-over-year alongside a 31.3% rise in profit after tax to Rs 18.11 crore, driven by improved capacity utilization, product diversification and healthy customer orders.